Rectal Cancer

IORT increases survival rate in rectal cancer study patients

Published in Health and Medicine Week, May 23rd, 2005

Intraop Medical Corporation (IOPM), manufacturer of the Mobetron, announced that according to research presented at a recent international meeting, intraoperative radiation therapy (IORT) increases survival rates in patients with advanced or recurrent rectal cancer.

IORT is a specialized treatment in which patients are given a dose of radiation therapy during surgery directly to the tumor site. IORT has proven to be a valuable adjunct therapy for treating many types of solid tumors.

In a presentation at the 4th International Society of IORT (ISIORT) meeting held in Miami, Florida, March 17-19, 2005, Harm Rutten, chief of surgical oncology and a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2005-05-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry